PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Apr-2020 Shenogen enters into an Exclusive License with BioArdis to Develop and Commercialize Novel FGFR4 Kinase Inhibitor for Asian Market BioArdis LLC
03-Apr-2020 Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline Servier
03-Apr-2020 Availability of Preparatory Documents for the Combined General Meeting of May 27, 2020 Transgene
03-Apr-2020 InsurTech Holdings, Life Epigenetics, and YouSurance are rebranding to FOXO BioScience FOXO BioScience
03-Apr-2020 Leica Biosystems Receives FDA's Enforcement Discretion For Use Of Aperio ImageScope DX Viewing Software For Remote Diagnosis During COVID-19 Emergency Leica Biosystems
03-Apr-2020 Gracell Announces China MNPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Gracell
03-Apr-2020 NMI® at 52.5%; March 2020 Non-Manufacturing ISM® Report On Business® Institute for Supply Management
03-Apr-2020 Coeliac UK launches appeal to keep support going for thousands with autoimmune disease National charity Coeliac UK
03-Apr-2020 The Alliance for Regenerative Medicine to Host FDA Representatives for Webinar on Clinical Trial Guidance During COVID-19 on April 10, 2020 The Alliance for Regenerative Medicine
03-Apr-2020 Availability of the Pre-quarterly Results Communication Sanofi
03-Apr-2020 Dupixent® (dupilumab) Phase 3 data show significant improvement in severe atopic dermatitis for children aged 6 to 11 years Sanofi
03-Apr-2020 Mistura Informatics Donates Medicines Information Software to Tackle COVID-19 Mistura Informatics
03-Apr-2020 Axon Presented Positive Phase II Trial Results of AADvac1 at AAT-AD/PD 2020 AXON Neuroscience SE
03-Apr-2020 Scientists on Standby portal launched to support the recruitment of overflow resource for the testing of COVID-19 Scientists on Standby
03-Apr-2020 Dupixent® (dupilumab) Phase 3 Data at Revolutionizing Atopic Dermatitis Conference Show Significant Improvement in Severe Atopic Dermatitis for Children Aged 6 to 11 Years Regeneron Pharmaceuticals, Inc.
02-Apr-2020 Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates Windtree Therapeutics, Inc.
02-Apr-2020 Kodiak Sciences Appoints Charles Bancroft to Board of Directors Kodiak Sciences Inc.
02-Apr-2020 New Publication Describes Mechanism of Action for Tb4 in Corneal Wound Healing and Regeneration RegeneRx Biopharmaceuticals, Inc.
02-Apr-2020 FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENCE APPLICATION FOR RYONCIL™ AND AGREES TO PRIORITY REVIEW Mesoblast Limited
02-Apr-2020 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ Emergent BioSolutions